The ClinicianThe ClinicianКлиницист1818-83382412-8775Publishing House ABV Press66110.17650/1818-8338-2025-19-2-K741LECTIONЛЕКЦИЯModern approaches to diagnosis and treatment of vestibular migraineСовременные подходы к диагностике и лечению вестибулярной мигрениhttps://orcid.org/0000-0003-2643-2699MasuevaS. S.МасуеваС. С.
Russian Federation

Seda Salakhovna Masueva

11/6 Yauzskaya Naberezhnaya, Moscow 109240, Russia; Build. 1, 2/1 Barrikadnaya St., Moscow 125993, Russia

Седа Салаховна Масуева 

Россия, 109240 Москва, ул. Яузская, 11/6; Россия, 125993 Москва, ул. Баррикадная, 2/1, стр. 1

masuevass@gmail.comhttps://orcid.org/0000-0002-0193-2243ZamergradM. V.ЗамерградМ. В.
Russian Federation

11/6 Yauzskaya Naberezhnaya, Moscow 109240, Russia; 161st Leonova St., Moscow 129226, Russia

Россия, 109240 Москва, ул. Яузская, 11/6; Россия, 129226 Москва, ул. 1-­я Леонова, 16

https://orcid.org/0000-0003-1539-4068GrachevS. P.ГрачевС. П.
Russian Federation

11/6 Yauzskaya Naberezhnaya, Moscow 109240, Russia; Build. 1, 20 Delegatskaya St., Moscow 127473, Russia

Россия, 109240 Москва, ул. Яузская, 11/6; Россия, 127473 Москва, ул. Делегатская, 20, стр. 1

I.V. Davydovskiy City Clinical Hospital, Moscow Healthcare DepartmentГБУЗ г. Москвы «Городская клиническая больница им. И.В. Давыдовского Департамента здравоохранения г. Москвы»Russian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaФГБУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииRussian Gerontological Scientific and Clinical Center of N.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaФГУ «Российский геронтологический научно-клинический центр РНИМУ им. Н.И. Пирогова» Минздрава РоссииRussian University of Medicine, Ministry of Health of RussiaФГБОУ ВО «Российский университет медицины» Минздрава России1504202519261670509202505092025Copyright ©; 2025, Masueva S.S., Zamergrad M.V., Grachev S.P.Copyright ©; 2025, Масуева С.С., Замерград М.В., Грачев С.П.2025Masueva S.S., Zamergrad M.V., Grachev S.P.Масуева С.С., Замерград М.В., Грачев С.П.https://creativecommons.org/licenses/by/4.0https://klinitsist.abvpress.ru/Klin/article/view/661

Vestibular migraine (VM) is a common but underdiagnosed form of migraine. The incidence of VM according to various population studies is about 3 %. Like other forms of migraines, VM is more common in women, especially of periand postmenopausal age. Apart from headaches and dizziness being the most frequent complaints to neurologists, according to the latest statistical data VM is also the most common cause of episodic vertigo. Currently, there aren’t any instrumental diagnostic methods that could confirm presence or absence of vestibular migraine. Diagnosis of this disease is based on results of clinical examination and anamnesis of the patient. Diagnostic criteria, jointly developed by the International Headache Society and the Barany Society, make it possible to diagnose probable or definitive vestibular migraine based exclusively on clinical and anamnestic data. Therapy of VM is based on the same principles as other migraines: relief of attacks and preventive therapy aimed at reducing the severity and frequency of the attacks. However, there are not enough studies on the effectiveness of classical antimigraine therapy in vestibular migraine, and currently in the medical community there are no generally accepted guidelines on treatment of this disease. Despite this, due to the accumulated experience of previous years, possibilities of vestibular migraine therapy are quite extensive and can be effectively applied in routine clinical practice of a neurologist.

Вестибулярная мигрень (ВМ) – часто встречающаяся, но все еще недостаточно диагностируемая форма мигрени. Распространенность ВМ, по данным различных популяционных исследований, составляет около 3 %. Как и другие формы мигрени, ВМ чаще встречается у женщин, особенно пери- и постменопаузального возраста. Помимо того, что головная боль и головокружение являются наиболее частыми жалобами на приеме у невролога, согласно последним статистическим данным, ВМ выступает самой распространенной причиной эпизодических головокружений. В настоящее время не существует ни одного инструментального диагностического метода, который мог бы подтвердить наличие или отсутствие ВМ. Диагностические критерии данного заболевания, разработанные совместно Международным обществом головной боли и Обществом Барани, позволяют диагностировать вероятную или достоверную ВМ, основываясь исключительно на клинических и анамнестических данных. Терапия ВМ складывается из тех же этапов, что и при мигрени в целом: купирование приступов и профилактическая терапия, направленная на уменьшение их выраженности и частоты. Однако исследований эффективности классической противомигренозной терапии в отношении ВМ все еще недостаточно, и на сегодняшний день в медицинском сообществе отсутствуют общепринятые рекомендации по лечению данного заболевания. Несмотря на это, благодаря накопленному опыту предыдущих лет, возможности терапии ВМ довольно обширны и могут эффективно применяться в рутинной клинической практике врача-невролога.

migrainevestibular migrainemigraine-associated vertigoheadachedizzinessvertigoinstabilityvestibular disordervestibulopathyмигреньвестибулярная мигреньмигрень-ассоциированное головокружениеголовная больголовокружениенеустойчивостьвестибулярные нарушениявестибулопатия1. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38(1):1–211. DOI: 10.1177/0333102417738202Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38(1):1–211. DOI: 10.1177/03331024177382022. Bisdorff A., Von Brevern M., Lempert T., Newman-Toker D.E. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res 2009;19(1–2): 1–13. DOI: 10.3233/VES-2009-0343Bisdorff A., Von Brevern M., Lempert T., Newman-Toker D.E. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res 2009;19(1–2): 1–13. DOI: 10.3233/VES-2009-03433. Calhoun A.H., Ford S., Pruitt A.P., Fisher K.G. The point prevalence of dizziness or vertigo in migraine and factors that influence presentation. Headache 2011;51(9):1388–92. DOI: 10.1111/j.1526-4610.2011.01970Calhoun A.H., Ford S., Pruitt A.P., Fisher K.G. The point prevalence of dizziness or vertigo in migraine and factors that influence presentation. Headache 2011;51(9):1388–92. DOI: 10.1111/j.1526-4610.2011.019704. Kang B.C., Kim T., Kwon J.K. Prevalence of vestibular migraine in an otolaryngologic clinic: preliminary clinical diagnosis versus diagnosis according to the strictly applied Bárány criteria. J Vestib Res 2023;33(2):137–42. DOI: 10.3233/VES-220112Kang B.C., Kim T., Kwon J.K. Prevalence of vestibular migraine in an otolaryngologic clinic: preliminary clinical diagnosis versus diagnosis according to the strictly applied Bárány criteria. J Vestib Res 2023;33(2):137–42. DOI: 10.3233/VES-2201125. Carvalho G.F., Vianna-Bell F.H., Florencio L.L. et al. Presence of vestibular symptoms and related disability in migraine with and without aura and chronic migraine. Cephalalgia 2019;39(1):29–37. DOI: 10.1177/0333102418769948Carvalho G.F., Vianna-Bell F.H., Florencio L.L. et al. Presence of vestibular symptoms and related disability in migraine with and without aura and chronic migraine. Cephalalgia 2019;39(1):29–37. DOI: 10.1177/03331024187699486. Huang T.C., Wang S.J., Kheradmand A. Vestibular migraine: an update on current understanding and future directions. Cephalalgia 2020;40(1):107–21. DOI: 10.1177/0333102419869317Huang T.C., Wang S.J., Kheradmand A. Vestibular migraine: an update on current understanding and future directions. Cephalalgia 2020;40(1):107–21. DOI: 10.1177/03331024198693177. Celebisoy N., Kısabay Ak А., Еzdemir H.N. et al. Vestibular migraine, demographic and clinical features of 415 patients: a multicenter study. Clin Neurol Neurosurg 2022;215:107201. DOI: 10.1016/j.clineuro.2022.107201Celebisoy N., Kısabay Ak А., Еzdemir H.N. et al. Vestibular migraine, demographic and clinical features of 415 patients: a multicenter study. Clin Neurol Neurosurg 2022;215:107201. DOI: 10.1016/j.clineuro.2022.1072018. Strupp M., Dlugaiczyk J., Ertl-Wagner B.B. et al. Vestibular disorders. Dtsch Arztebl Int 2020;117(17):300–10. DOI: 10.3238/arztebl.2020.0300Strupp M., Dlugaiczyk J., Ertl-Wagner B.B. et al. Vestibular disorders. Dtsch Arztebl Int 2020;117(17):300–10. DOI: 10.3238/arztebl.2020.03009. Lempert T., Olesen J., Furman J. et al. Vestibular migraine: diagnostic criteria1. J Vestib Res 2022;32(1):1–6. DOI: 10.3233/VES-201644Lempert T., Olesen J., Furman J. et al. Vestibular migraine: diagnostic criteria1. J Vestib Res 2022;32(1):1–6. DOI: 10.3233/VES-20164410. Teggi R., Colombo B., Albera R. et al. Clinical features, familial history, and migraine precursors in patients with definite vestibular migraine: the VM-phenotypes projects. Headache 2018;58(4): 534–44. DOI: 10.1111/head.13240Teggi R., Colombo B., Albera R. et al. Clinical features, familial history, and migraine precursors in patients with definite vestibular migraine: the VM-phenotypes projects. Headache 2018;58(4): 534–44. DOI: 10.1111/head.1324011. Young A.S., Nham B., Bradshaw A.P. et al. Clinical, oculographic, and vestibular test characteristics of vestibular migraine. Cephalalgia 2021;41(10):1039–52. DOI: 10.1177/03331024211006042Young A.S., Nham B., Bradshaw A.P. et al. Clinical, oculographic, and vestibular test characteristics of vestibular migraine. Cephalalgia 2021;41(10):1039–52. DOI: 10.1177/0333102421100604212. Wattiez A.S., O’Shea S.A., Ten Eyck P. et al. Patients with vestibular migraine are more likely to have occipital headaches than those with migraine without vestibular symptoms. Headache 2020;60(8):1581–91. DOI: 10.1111/head.13898Wattiez A.S., O’Shea S.A., Ten Eyck P. et al. Patients with vestibular migraine are more likely to have occipital headaches than those with migraine without vestibular symptoms. Headache 2020;60(8):1581–91. DOI: 10.1111/head.1389813. Cha Y.H., Lee H., Santell L.S., Baloh R.W. Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia 2009;29(5):550–5. DOI: 10.1111/j.1468-2982.2008.01770Cha Y.H., Lee H., Santell L.S., Baloh R.W. Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia 2009;29(5):550–5. DOI: 10.1111/j.1468-2982.2008.0177014. Guerra-Jiménez G., Arenas Rodríguez A., Falcón González J.C. et al. Epidemiology of vestibular disorders in the otoneurology unit. Acta Otorrinolaringol Esp (Engl Ed) 2017;68(6):317–22. DOI: 10.1016/j.otorri.2017.01.007Guerra-Jiménez G., Arenas Rodríguez A., Falcón González J.C. et al. Epidemiology of vestibular disorders in the otoneurology unit. Acta Otorrinolaringol Esp (Engl Ed) 2017;68(6):317–22. DOI: 10.1016/j.otorri.2017.01.00715. Dieterich M., Obermann M., Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. J Neurol 2016;263(1):82–9. DOI:10.1007/s00415-015-7905-2Dieterich M., Obermann M., Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. J Neurol 2016;263(1):82–9. DOI:10.1007/s00415-015-7905-216. Perez-Carpena P., Lopez-Escamez J.A. Do we need to reconsider the classification of vestibular migraine? Expert Rev Neurother 2021;21(5):503–16. DOI: 10.1080/14737175.2021Perez-Carpena P., Lopez-Escamez J.A. Do we need to reconsider the classification of vestibular migraine? Expert Rev Neurother 2021;21(5):503–16. DOI: 10.1080/14737175.202117. Casani A.P., Sellari-Franceschini S., Napolitano A. et al. Otoneurologic dysfunctions in migraine patients with or without vertigo. Otol Neurotol 2009;30(7):961–7. DOI: 10.1097/MAO.0b013e3181b4e780Casani A.P., Sellari-Franceschini S., Napolitano A. et al. Otoneurologic dysfunctions in migraine patients with or without vertigo. Otol Neurotol 2009;30(7):961–7. DOI: 10.1097/MAO.0b013e3181b4e78018. Radtke A., von Brevern M., Neuhauser H. et al. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulocochlear findings. Neurology 2012;79(15):1607–14. DOI: 10.1212/WNL.0b013e31826e264fRadtke A., von Brevern M., Neuhauser H. et al. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulocochlear findings. Neurology 2012;79(15):1607–14. DOI: 10.1212/WNL.0b013e31826e264f19. Von Brevern M., Zeise D., Neuhauser H. et al. Acute migrainous vertigo: сlinical and oculographic findings. Brain 2005;128(2): 365–74. DOI: 10.1093/brain/awh351Von Brevern M., Zeise D., Neuhauser H. et al. Acute migrainous vertigo: сlinical and oculographic findings. Brain 2005;128(2): 365–74. DOI: 10.1093/brain/awh35120. Carmona S., Zalazar G.J., Fernandez M. et al. Atypical positional vertigo: definition, causes, and mechanisms. Audiol Res 2022;12(2):152–61. DOI: 10.3390/audiolres12020018Carmona S., Zalazar G.J., Fernandez M. et al. Atypical positional vertigo: definition, causes, and mechanisms. Audiol Res 2022;12(2):152–61. DOI: 10.3390/audiolres1202001821. Polensek S.H., Tusa R.J. Nystagmus during attacks of vestibular migraine: an aid in diagnosis. Audiol Neurootol 2010;15(4):241–6. DOI: 10.1159/000255440Polensek S.H., Tusa R.J. Nystagmus during attacks of vestibular migraine: an aid in diagnosis. Audiol Neurootol 2010;15(4):241–6. DOI: 10.1159/00025544022. Jeong S.H., Oh S.Y., Kim H.J. et al. Vestibular dysfunction Lection in migraine: effects of associated vertigo and motion sickness. J Neurol 2009;257(6):905–12. DOI: 10.1007/s00415-009-5435-5Jeong S.H., Oh S.Y., Kim H.J. et al. Vestibular dysfunction Lection in migraine: effects of associated vertigo and motion sickness. J Neurol 2009;257(6):905–12. DOI: 10.1007/s00415-009-5435-523. Baier B., Stieber N., Dieterich M. Vestibular-evoked myogenic potentials in vestibular migraine. J Neurol 2009;256(9):1447–54. DOI: 10.1007/s00415-009-5132-4Baier B., Stieber N., Dieterich M. Vestibular-evoked myogenic potentials in vestibular migraine. J Neurol 2009;256(9):1447–54. DOI: 10.1007/s00415-009-5132-424. Boldingh M.I., Ljøstad U., Mygland A., Monstad P. Vestibular sensitivity in vestibular migraine: vEMPs and motion sickness susceptibility. Cephalalgia 2011;31(11):1211–9. DOI: 10.1177/0333102411409074Boldingh M.I., Ljøstad U., Mygland A., Monstad P. Vestibular sensitivity in vestibular migraine: vEMPs and motion sickness susceptibility. Cephalalgia 2011;31(11):1211–9. DOI: 10.1177/033310241140907425. Taylor R.L., Zagami A.S., Gibson W.P. et al. Vestibular evoked myogenic potentials to sound and vibration: characteristics in vestibular migraine that enable separation from Meniere’s disease. Cephalalgia 2012;32(3):213–25. DOI: 10.1177/0333102411434166Taylor R.L., Zagami A.S., Gibson W.P. et al. Vestibular evoked myogenic potentials to sound and vibration: characteristics in vestibular migraine that enable separation from Meniere’s disease. Cephalalgia 2012;32(3):213–25. DOI: 10.1177/033310241143416626. Kandemir A., Çelebisoy N., Köse T. Cervical vestibular evoked myogenic potentials in primary headache disorders. Clin Neurophysiol 2013;124(4):779–84. DOI: 10.1016/j.clinph.2012.09.027Kandemir A., Çelebisoy N., Köse T. Cervical vestibular evoked myogenic potentials in primary headache disorders. Clin Neurophysiol 2013;124(4):779–84. DOI: 10.1016/j.clinph.2012.09.02727. Kandemir A., Çelebisoy N., Köse T. Perception of verticality in patients with primary headache disorders. J Int Adv Otol 2014;10(2):38–43. DOI: 10.5152/iao.2014.25Kandemir A., Çelebisoy N., Köse T. Perception of verticality in patients with primary headache disorders. J Int Adv Otol 2014;10(2):38–43. DOI: 10.5152/iao.2014.2528. Замерград М.В. Лечение вестибулярной мигрени. Эффективная фармакотерапия 2021;17(29):32–6. DOI: 10.33978/2307-3586-2021-17-29-32-36 Zamergrad M.V. Vestibular migraine treatment. Effektivnaya farmakoterapiya = Effective Pharmacotherapy 2021;17(29):32–6. (In Russ.). DOI: 10.33978/2307-3586-2021-17-29-32-36Замерград М.В. Лечение вестибулярной мигрени. Эффективная фармакотерапия 2021;17(29):32–6. DOI: 10.33978/2307-3586-2021-17-29-32-36 Zamergrad M.V. Vestibular migraine treatment. Effektivnaya farmakoterapiya = Effective Pharmacotherapy 2021;17(29):32–6. (In Russ.). DOI: 10.33978/2307-3586-2021-17-29-32-3629. Масуева С.С., Замерград М.В. Принципы медикаментозного лечения острого вестибулярного головокружения. Медицинский алфавит 2020;1(11):32–5. DOI: 10.33667/2078-5631-2020-11-32-35 Masueva S.S., Zamergrad M.V. Drug treatment of acute vertigo. Meditsinskiy alfavit = Medical Alphabet 2020;1(11):32–5. (In Russ.). DOI: 10.33667/2078-5631-2020-11-32-35Масуева С.С., Замерград М.В. Принципы медикаментозного лечения острого вестибулярного головокружения. Медицинский алфавит 2020;1(11):32–5. DOI: 10.33667/2078-5631-2020-11-32-35 Masueva S.S., Zamergrad M.V. Drug treatment of acute vertigo. Meditsinskiy alfavit = Medical Alphabet 2020;1(11):32–5. (In Russ.). DOI: 10.33667/2078-5631-2020-11-32-3530. Smyth D., Britton Z., Murdin L. et al. Vestibular migraine treatment: a comprehensive practical review. Brain 2022;145(11):3741–54. DOI: 10.1093/brain/awac264Smyth D., Britton Z., Murdin L. et al. Vestibular migraine treatment: a comprehensive practical review. Brain 2022;145(11):3741–54. DOI: 10.1093/brain/awac26431. Neuhauser H., Radtke A., von Brevern M., Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology 2003;60(5):882–3. DOI: 10.1212/01.wnl.0000049476.40047.a3Neuhauser H., Radtke A., von Brevern M., Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology 2003;60(5):882–3. DOI: 10.1212/01.wnl.0000049476.40047.a332. Baloh R.W. Rizatriptan for episodic dizziness in vestibular migraine. Updated 4 November 2021. Available at https://clinicaltrials.gov/ct2/show/study/NCT02447991Baloh R.W. Rizatriptan for episodic dizziness in vestibular migraine. Updated 4 November 2021. Available at https://clinicaltrials.gov/ct2/show/study/NCT0244799133. Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope 2006;116(10):1782–6. DOI: 10.1097/01.mlg.0000231302.77922.c5Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope 2006;116(10):1782–6. DOI: 10.1097/01.mlg.0000231302.77922.c534. Cassano D., Pizza V., Busillo V. P074. Almotriptan in the acute treatment of vestibular migraine: a retrospective study. J Headache Pain 2015;16(1):A114. DOI: 10.1186/1129-2377-16-S1-A114Cassano D., Pizza V., Busillo V. P074. Almotriptan in the acute treatment of vestibular migraine: a retrospective study. J Headache Pain 2015;16(1):A114. DOI: 10.1186/1129-2377-16-S1-A11435. Schremmer D., Bognar-Steinberg I., Baumann W., Pytel J. Efficacy and tolerability of a fixed combination of cinnarizineand dimenhydrinate in treatment of vertigo. Clin Drug Investig 1999;18:355–68. DOI: 10.2165/00044011-199918050-00003Schremmer D., Bognar-Steinberg I., Baumann W., Pytel J. Efficacy and tolerability of a fixed combination of cinnarizineand dimenhydrinate in treatment of vertigo. Clin Drug Investig 1999;18:355–68. DOI: 10.2165/00044011-199918050-0000336. Scholtz A.W., Steindl R., Burchardi N. et al. Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study. Clin Drug Investig 2012:32(6):387–99. DOI: 10.2165/11632410-000000000-00000.Scholtz A.W., Steindl R., Burchardi N. et al. Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study. Clin Drug Investig 2012:32(6):387–99. DOI: 10.2165/11632410-000000000-00000.37. Ramón C., Cernuda-Morollón E., Pascual J. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine. Curr Opin Neurol 2017;30(3):281–6. DOI: 10.1097/WCO.0000000000000440Ramón C., Cernuda-Morollón E., Pascual J. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine. Curr Opin Neurol 2017;30(3):281–6. DOI: 10.1097/WCO.000000000000044038. Liu F., Ma T., Che X. et al. The Efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol 2017;8:524. DOI: 10.3389/fneur.2017.00524Liu F., Ma T., Che X. et al. The Efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol 2017;8:524. DOI: 10.3389/fneur.2017.0052439. Salviz M., Yuce T., Acar H. et al. Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized controlled trial. Laryngoscope 2016;126(1):169–74. DOI: 10.1002/lary.25445Salviz M., Yuce T., Acar H. et al. Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized controlled trial. Laryngoscope 2016;126(1):169–74. DOI: 10.1002/lary.2544540. Lempert T., von Brevern M. Vestibular migraine. Neurol Clin 2019;37(4):695–706. DOI: 10.1016/j.ncl.2019.06.003Lempert T., von Brevern M. Vestibular migraine. Neurol Clin 2019;37(4):695–706. DOI: 10.1016/j.ncl.2019.06.00341. Von Brevern M., Lempert T. Vestibular migraine: treatment and prognosis. Semin Neurol 2020;40(1):83–6. DOI: 10.1055/s-0039-3402067Von Brevern M., Lempert T. Vestibular migraine: treatment and prognosis. Semin Neurol 2020;40(1):83–6. DOI: 10.1055/s-0039-340206742. Li G., Xu J., Zhou X. et al. The efficacy of topiramate and flunarizine hydrochloride for prophylactic treatment of vestibular migraine. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2021;35(9):784–7;795. DOI: 10.13201/j.issn.2096-7993.2021.09.004Li G., Xu J., Zhou X. et al. The efficacy of topiramate and flunarizine hydrochloride for prophylactic treatment of vestibular migraine. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2021;35(9):784–7;795. DOI: 10.13201/j.issn.2096-7993.2021.09.00443. Антоненко Л.М., Парфенов В.А. Реабилитация пациентов с вестибулярными нарушениями. Медицинский совет 2017;(1):33–7. DOI: 10.21518/2079-701X-2017-0-33-37 Antonenko L.M., Parfenov V.A. Rehabilitation of patients with vestibular disorders. Meditsinskiy sovet = Medical Advice 2017;(1):33–7. (In Russ.). DOI: 10.21518/2079-701X-2017-0-33-37Антоненко Л.М., Парфенов В.А. Реабилитация пациентов с вестибулярными нарушениями. Медицинский совет 2017;(1):33–7. DOI: 10.21518/2079-701X-2017-0-33-37 Antonenko L.M., Parfenov V.A. Rehabilitation of patients with vestibular disorders. Meditsinskiy sovet = Medical Advice 2017;(1):33–7. (In Russ.). DOI: 10.21518/2079-701X-2017-0-33-3744. Çelebisoy N., Gökçay F., Karahan C. et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol 2016;273(10):2947–51. DOI: 10.1007/s00405-015-3874-4Çelebisoy N., Gökçay F., Karahan C. et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol 2016;273(10):2947–51. DOI: 10.1007/s00405-015-3874-445. Taghdiri F., Togha M., Razeghi Jahromi S., Refaeian F. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Springerplus 2014;3:231. DOI: 10.1186/2193-1801-3-231Taghdiri F., Togha M., Razeghi Jahromi S., Refaeian F. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Springerplus 2014;3:231. DOI: 10.1186/2193-1801-3-231